Ensitrelvir clinical trials
Also written S-217622.
How each study uses ensitrelvir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the ensitrelvir studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 29 May 2026 · XOCOVA · NDA 220442 (FDA, Drugs@FDA)
- European Union
- 18 Sept 2026 · Zokovea · EMEA/H/C/006063 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
8 studies that test it; most in 2022 (4)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 3
Shionogi (5) · Timothy Henrich (1) · University of Oxford (1) · University of Minnesota (1)
Often tested with
Tested in the same studies.
Nirmatrelvir and ritonavir drug combination (1) · Nitazoxanide (1) · Molnupiravir (1) · Nirmatrelvir (1) · Hydroxychloroquine (1) · Antibodies, Monoclonal (1) · Fluoxetine (1) · Sotrovimab (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test ensitrelvir.
- Jan 2027Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)Phase 2 · University of Oxford
Studies
Open first, then newest update. How each study uses ensitrelvir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)RecruitingPhase 2University of OxfordNCT05041907Written as Ensitrelvir
- Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 InfectionCompletedPhase 3ShionogiNCT05897541Written as S-217622
- Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor (Ensitrelvir)TerminatedPhase 3University of MinnesotaNCT05605093Written as Shionogi Protease Inhibitor (S-217622)
- A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19CompletedPhase 3ShionogiNCT05305547Written as S-217622
- Ensitrelvir for Viral Persistence and Inflammation in People Experiencing Long COVIDActive, not recruitingPhase 2Timothy HenrichNCT06161688Written as Ensitrelvir
- A Drug-Drug Interaction Study of S-217622 With Combined Oral Contraceptives in Healthy Adult Female ParticipantsCompletedPhase 1ShionogiNCT06775730Written as Ensitrelvir
- A Study to Assess S-217622 in Participants With Mild and Moderate Hepatic Impairment and Healthy Control ParticipantsCompletedPhase 1ShionogiNCT05409911Written as S-217622
- A Study to Assess S-217622 in Participants With Renal Impairment and Healthy ParticipantsCompletedPhase 1ShionogiNCT05363215Written as S-217622
Codes
What other systems call ensitrelvir · ClinicalTrials.gg INT001840
- MeSH (NLM) C000722354ensitrelvirConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) PX665RAA3HENSITRELVIRConfirmed FDA, NLM, Wikidata
- Wikidata Q110798570ensitrelvirConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C188613EnsitrelvirOne source FDA
- DrugBank DB18834One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000722354 | ensitrelvir | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | PX665RAA3H | ENSITRELVIR | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q110798570 | ensitrelvir | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C188613 | Ensitrelvir | One source FDA |
| DrugBank | DB18834 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.